| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cea139ad438b9ce7d33159d45b154c6b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16322 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-055 |
| filingDate |
1992-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea141fb14444df2c915862fd6cca4361 |
| publicationDate |
1994-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0591384-A1 |
| titleOfInvention |
Attenuated revertant serotype 1 marek's disease vaccine |
| abstract |
A vaccine against Marek's disease comprising an attenuated inversion virus derived as a clone of Md11 / 75 / R2 or an antigenic component of the virus is characterized by considerably reduced pathogenicity compared to the parent virus, without this being accompanied by '' a comparable loss in immunogenicity. Examples of attenuated inversion viruses of the invention are Md11 / 75 / R2 / 23 and Md11 / 75 / R2 / 29. These viruses or their immunogenic components can be formulated as a monovalent and versatile vaccine. |
| priorityDate |
1991-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |